Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

被引:0
|
作者
Xiao-yu Jia
Jun-tao Yu
Shui-yi Hu
Jian-nan Li
Miao Wang
Chen Wang
Min Chen
Zhao Cui
Ming-hui Zhao
机构
[1] Peking University First Hospital,Renal Division, Department of Medicine; Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China
[2] Peking University,Academy for Advanced Interdisciplinary Studies
[3] Peking-Tsinghua Center for Life Sciences,undefined
来源
Clinical Rheumatology | 2017年 / 36卷
关键词
ANCA; Anti-GBM antibodies; Crescentic glomerulonephritis; Linear epitopes; α3(IV)NC1;
D O I
暂无
中图分类号
学科分类号
摘要
In a substantial number of patients with crescentic glomerulonephritis, both anti-glomerular basement membrane (GBM) antibodies and anti-neutrophil cytoplasmic antibodies (ANCA) are detected simultaneously. ANCA is presumed to be the initial event but the mechanism is unknown. In the present study, we investigated the antibodies against linear epitopes on Goodpasture autoantigen in sera from patients with ANCA-associated vasculitis, aiming to reveal the mechanisms of the coexistence of the two kinds of autoantibodies. Thirty-one patients with ANCA-associated vasculitis were enrolled in this study. Twenty-four overlapping linear peptides were synthesized across the whole sequence of Goodpasture autoantigen. Serum antibodies against linear peptides were detected by ELISA and their associations with clinical features were further analyzed. Twenty-five out of the thirty-one (80.6%) sera from patients with ANCA-associated vasculitis possessed antibodies against linear peptides on Goodpasture autoantigen. These antibodies could be detected in 50% of patients with normal renal function (Scr ≤ 133 μmol/L), 70% of patients with moderate renal dysfunction (133 μmol/L < Scr ≤ 600 μmol/L), and 94% of patients with renal failure (Scr > 600 μmol/L) (P = 0.032). The highest recognition frequencies were found for peptides P4 (51.6%), P14 (54.8%), and P24 (54.8%), which contained the sequences that constitute the conformational epitopes of EA (P4) and EB (P14) recognized by anti-GBM antibodies. The level of anti-P4 antibodies was positively correlated with the percentage of crescents in glomeruli (r = 0.764, P = 0.027). Patients with anti-P24 antibodies had a significantly higher prevalence of renal dysfunction on diagnosis (88.2 vs. 42.9%, P = 0.018). Antibodies against linear epitopes on Goodpasture autoantigen could be detected in sera of patients with ANCA-associated vasculitis, which might mediate the production of antibodies towards the conformational epitopes on Goodpasture autoantigen, namely, the anti-GBM antibodies.
引用
收藏
页码:2087 / 2094
页数:7
相关论文
共 50 条
  • [1] Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
    Jia, Xiao-yu
    Yu, Jun-tao
    Hu, Shui-yi
    Li, Jian-nan
    Wang, Miao
    Wang, Chen
    Chen, Min
    Cui, Zhao
    Zhao, Ming-hui
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 2087 - 2094
  • [2] Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Gan, Poh-Yi
    Ooi, Joshua D.
    Kitching, A. Richard
    Holdsworth, Stephen R.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (18) : 2380 - 2390
  • [3] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Sun, Xiao-Jing
    Li, Zhi-Ying
    Chen, Min
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 11 - 21
  • [4] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [5] Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Alberici, Federico
    Martorana, Davide
    Vaglio, Augusto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i37 - i45
  • [6] Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Coughlan, A. M.
    Freeley, S. J.
    Robson, M. G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (03) : 229 - 237
  • [7] Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
    Gou, Shen-Ju
    Yuan, Jun
    Chen, Min
    Yu, Feng
    Zhao, Ming-Hui
    KIDNEY INTERNATIONAL, 2013, 83 (01) : 129 - 137
  • [8] Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission
    Muto, Reiko
    Inagaki, Koji
    Sato, Naokazu
    Sameshima, Tetsuro
    Nagakura, Yuka
    Baba, Satoshi
    Kato, Noritoshi
    Maruyama, Shoichi
    Akahori, Toshiyuki
    INTERNAL MEDICINE, 2020, 59 (24) : 3187 - 3193
  • [9] A case of Sjogren syndrome and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Kaynar, K.
    Guvercin, B.
    Sengor, A.
    Mungan, S.
    REUMATISMO, 2023, 75 (02) : 93 - 97
  • [10] Clinicopathological features of neuropathy in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Koike, Haruki
    Sobue, Gen
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (05) : 683 - 685